This is at odds with the proposed action on stimulating CD8+ T-cell function, however in an already diabetic context, the use of insulin may be a sign of progressed diabetes and thus an overall less healthy metabolic status of the patient. The gene discussed is CD8A; the disease is diabetes mellitus.